Document is current
Any future updates will be listed below
-
Authors
Kjaer, Trille Kristina https://orcid.org/0000-0002-1917-4241
Levinsen, Anne Katrine Graudal https://orcid.org/0000-0003-0906-1873
Jakobsen, Erik https://orcid.org/0000-0002-0052-7705
Gögenur, Ismail https://orcid.org/0000-0002-3753-268X
Borre, Michael https://orcid.org/0000-0002-1519-9185
Christiansen, Peer https://orcid.org/0000-0003-2748-9240
Zachariae, Robert https://orcid.org/0000-0001-9076-3068
Christensen, Peter https://orcid.org/0000-0002-6611-3935
de Nully Brown, Peter https://orcid.org/0000-0002-6522-4086
Hölmich, Lisbet Rosenkrantz https://orcid.org/0000-0002-1983-5222
Johansen, Christoffer https://orcid.org/0000-0002-4384-206X
Kjær, Susanne Krüger https://orcid.org/0000-0002-8347-1398
van de Poll-Franse, Lonneke https://orcid.org/0000-0003-0413-6872
Dalton, Susanne Oksbjerg https://orcid.org/0000-0002-5485-2730
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18OC0052543)
Kræftens Bekæmpelse (R269-A15811)
Kræftens Bekæmpelse (R364-A21129)
Helsefonden (20-B-0434)
- License Information
-
More Information
Article History
Received: 14 August 2025
Revised: 2 February 2026
Accepted: 17 February 2026
First Online: 28 February 2026
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki. The study was approved by the National Board of Health Data (Region Zealand (REG-059–2021)). Ethical review and approval were waived for this study, as no human biological material was included in the project. The study was registered in the Danish Cancer Society Research Database (2019-DCRC-0066). We obtained informed consent from all participants in the study. The data was stored and protected following the guidelines of the Danish legislation regarding GDPR.
: The authors declare no competing interests.
